These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38503386)

  • 1. Impact of controlled hypothermic preservation on outcomes following heart transplantation.
    D'Alessandro D; Schroder J; Meyer DM; Vidic A; Shudo Y; Silvestry S; Leacche M; Sciortino CM; Rodrigo ME; Pham SM; Copeland H; Jacobs JP; Kawabori M; Takeda K; Zuckermann A
    J Heart Lung Transplant; 2024 Jul; 43(7):1153-1161. PubMed ID: 38503386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Outcomes in Patients With LVAD Undergoing Heart Transplant via Use of the SherpaPak Cardiac Transport System.
    Lerman JB; Patel CB; Casalinova S; Nicoara A; Holley CL; Leacche M; Silvestry S; Zuckermann A; D'Alessandro DA; Milano CA; Schroder JN; DeVore AD
    Circ Heart Fail; 2024 May; 17(5):e010904. PubMed ID: 38602105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Paradigm Shift in Heart Preservation: Improved Post-transplant Outcomes in Recipients of Donor Hearts Preserved With the SherpaPak System.
    Shudo Y; Leacche M; Copeland H; Silvestry S; Pham SM; Molina E; Schroder JN; Sciortino CM; Jacobs JP; Kawabori M; Meyer DM; Zuckermann A; D'Alessandro DA
    ASAIO J; 2023 Nov; 69(11):993-1000. PubMed ID: 37678260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histidine-Tryptophan-Ketoglutarate Solution for Donor Heart Preservation Is Safe for Transplantation.
    Mokbel M; Zamani H; Lei I; Chen YE; Romano MA; Aaronson KD; Haft JW; Pagani FD; Tang PC
    Ann Thorac Surg; 2020 Mar; 109(3):763-770. PubMed ID: 31470011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothermic oxygenated perfusion of the donor heart in heart transplantation: the short-term outcome from a randomised, controlled, open-label, multicentre clinical trial.
    Rega F; Lebreton G; Para M; Michel S; Schramm R; Begot E; Vandendriessche K; Kamla C; Gerosa G; Berman M; Boeken U; Clark S; Ranasinghe A; Ius F; Forteza A; Pivodic A; Hennig F; Guenther S; Zuckermann A; Knosalla C; Dellgren G; Wallinder A;
    Lancet; 2024 Aug; 404(10453):670-682. PubMed ID: 39153817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended post-ex vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: Results from a multicentric study.
    Leiva-Juárez MM; Urso A; Arango Tomás E; Lederer DJ; Sanchez P; Griffith B; Davis RD; Daneshmand M; Hartwig M; Cantu E; Weyant MJ; Bermudez C; D'Cunha J; Machuca T; Wozniak T; Lynch W; Nemeh H; Mulligan M; Song T; Jessen M; Camp PC; Caldeira C; Whitson B; Kreisel D; Ramzy D; D'Ovidio F
    J Heart Lung Transplant; 2020 Sep; 39(9):954-961. PubMed ID: 32475748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation.
    Moayedi Y; Truby LK; Foroutan F; Han J; Guzman J; Angleitner P; Sabatino M; Felius J; VAN Zyl JS; Rodenas-Alesina E; Fan CP; Devore AD; Miller R; Potena L; Zuckermann A; Farrero M; Chih S; Farr M; Hall S; Ross HJ; Khush KK
    J Card Fail; 2024 Jun; 30(6):805-815. PubMed ID: 37907150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Severe Primary Graft Dysfunction in Infants Following Heart Transplant.
    Singh TP; Profita EL; Rycus P; Thiagarajan R; Gauvreau K
    J Am Heart Assoc; 2021 Jul; 10(13):e021082. PubMed ID: 34184543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death.
    Ayer A; Truby LK; Schroder JN; Casalinova S; Green CL; Bishawi MA; Bryner BS; Milano CA; Patel CB; Devore AD
    J Card Fail; 2023 Jan; 29(1):67-75. PubMed ID: 36351494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant.
    Benck L; Kransdorf EP; Emerson DA; Rushakoff J; Kittleson MM; Klapper EB; Megna DJ; Esmailian F; Halprin C; Trento A; Ramzy D; Czer LSC; Chang DH; Ebinger JE; Kobashigawa JA; Patel JK
    J Heart Lung Transplant; 2021 Sep; 40(9):970-980. PubMed ID: 34272125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients.
    Profita EL; Gauvreau K; Rycus P; Thiagarajan R; Singh TP
    J Heart Lung Transplant; 2019 Jun; 38(6):601-608. PubMed ID: 30733156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in Heart Transplant Recipients by Bridge to Transplant Strategy When Using the SherpaPak Cardiac Transport System.
    Silvestry S; Leacche M; Meyer DM; Shudo Y; Kawabori M; Mahesh B; Zuckermann A; D'Alessandro D; Schroder J
    ASAIO J; 2024 May; 70(5):388-395. PubMed ID: 38300893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Cardiac Troponin I in Preservation Solution Is Associated With Primary Graft Dysfunction.
    Schechter MA; Watson MJ; Feger BJ; Southerland KW; Mishra R; Dibernardo LR; Kuchibhatla M; Schroder JN; Daneshmand MA; Patel CB; Rogers JG; Milano CA; Bowles DE
    J Card Fail; 2016 Feb; 22(2):158-62. PubMed ID: 26365053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothermic oxygenated perfusion (HOPE) safely and effectively extends acceptable donor heart preservation times: Results of the Australian and New Zealand trial.
    McGiffin DC; Kure CE; Macdonald PS; Jansz PC; Emmanuel S; Marasco SF; Doi A; Merry C; Larbalestier R; Shah A; Geldenhuys A; Sibal AK; Wasywich CA; Mathew J; Paul E; Cheshire C; Leet A; Hare JL; Graham S; Fraser JF; Kaye DM
    J Heart Lung Transplant; 2024 Mar; 43(3):485-495. PubMed ID: 37918701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recipient Outcomes With Extended Criteria Donors Using Advanced Heart Preservation: An Analysis of the GUARDIAN-Heart Registry.
    Moayedifar R; Shudo Y; Kawabori M; Silvestry S; Schroder J; Meyer DM; Jacobs JP; D'Alessandro D; Zuckermann A
    J Heart Lung Transplant; 2024 Apr; 43(4):673-680. PubMed ID: 38163452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor heart ischemic time can be extended beyond 9 hours using hypothermic machine perfusion in sheep.
    See Hoe LE; Li Bassi G; Wildi K; Passmore MR; Bouquet M; Sato K; Heinsar S; Ainola C; Bartnikowski N; Wilson ES; Hyslop K; Skeggs K; Obonyo NG; Shuker T; Bradbury L; Palmieri C; Engkilde-Pedersen S; McDonald C; Colombo SM; Wells MA; Reid JD; O'Neill H; Livingstone S; Abbate G; Haymet A; Jung JS; Sato N; James L; He T; White N; Redd MA; Millar JE; Malfertheiner MV; Molenaar P; Platts D; Chan J; Suen JY; McGiffin DC; Fraser JF
    J Heart Lung Transplant; 2023 Aug; 42(8):1015-1029. PubMed ID: 37031869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor hyperoxia is a novel risk factor for severe cardiac primary graft dysfunction.
    Kransdorf EP; Rushakoff JA; Han J; Benck L; Malinoski D; Emerson D; Catarino P; Rampolla R; Kobashigawa JA; Khush KK; Patel JK
    J Heart Lung Transplant; 2023 May; 42(5):617-626. PubMed ID: 36682894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre†.
    Squiers JJ; Saracino G; Chamogeorgakis T; MacHannaford JC; Rafael AE; Gonzalez-Stawinski GV; Hall SA; DiMaio JM; Lima B
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):263-270. PubMed ID: 28186268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled temperatures in cold preservation provides safe heart transplantation results.
    Bitargil M; Haddad O; Pham SM; Goswami RM; Patel PC; Jacob S; El-Sayed Ahmed MM; Leoni Moreno JC; Yip DS; Landolfo K; Sareyyupoglu B
    J Card Surg; 2022 Apr; 37(4):732-738. PubMed ID: 35060167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for early primary graft dysfunction after lung transplantation: a registry study.
    Kuntz CL; Hadjiliadis D; Ahya VN; Kotloff RM; Pochettino A; Lewis J; Christie JD
    Clin Transplant; 2009; 23(6):819-30. PubMed ID: 19239481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.